nsc 297170 has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogden, AE; Hartmann, RW; Kranzfelder, G; Schönenberger, H; von Angerer, E | 1 |
| Hartmann, RW | 1 |
2 other study(ies) available for nsc 297170 and Breast Neoplasms
| Article | Year |
|---|---|
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Breast Neoplasms; Castration; Cell Line; Chemical Phenomena; Chemistry; Female; Hexestrol; Humans; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Rats; Rats, Inbred Strains; Receptors, Estrogen | 1982 |
Screening procedure for the development of mammary tumour-inhibiting anti-oestrogens.
Topics: Animals; Breast Neoplasms; Cattle; Chickens; Drug Evaluation, Preclinical; Estrogen Antagonists; Female; Hexestrol; Humans; In Vitro Techniques; Liver; Male; Mammary Neoplasms, Experimental; Mice; Rats; Rats, Inbred Strains; Receptors, Estradiol; Receptors, Estrogen; Uterus | 1984 |